Eloxx director granted 13,587 stock options
Eloxx Pharmaceuticals director Nina S. Kjellson received a grant of stock options covering 13,587 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Eloxx Pharmaceuticals director Nina S. Kjellson received a grant of stock options covering 13,587 shares of Common Stock. The options have an exercise price of $11.00 per share and expire on June 8, 2036. They vest in 24 substantially equal monthly installments over two years, conditioned on her continued service. Following this grant, she holds 13,587 stock options directly, reflecting a compensation-related award rather than an open-market purchase or sale.
Insider Trade Summary
Grant/Award: 13,587 shares
Grant/Award
1 txn
Insider
Kjellson Nina S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 13,587 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 13,587 contracts (Direct)
Footnotes (1)
- F1. The stock option will vest in 24 substantially equal monthly installments so that the option will be fully vested and exercisable on the second anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.
Key Figures
Options granted: 13,587 options
Exercise price: $11.00 per share
Expiration date: June 8, 2036
+3 more
6 metrics
Options granted
13,587 options
Stock Option (Right to Buy) grant to director
Exercise price
$11.00 per share
Stock option strike price for Common Stock
Expiration date
June 8, 2036
Option term end date
Shares underlying options
13,587 shares
Underlying Common Stock for the option grant
Vesting schedule
24 monthly installments
Fully vested on second anniversary of grant date
Total options after grant
13,587 options
Total derivative holdings following transaction
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, Common Stock, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "11.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-08T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest in 24 substantially equal monthly installments financial
"The stock option will vest in 24 substantially equal monthly installments"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Eloxx Pharmaceuticals (ELOX) report for Nina S. Kjellson?
Eloxx reported that director Nina S. Kjellson received a grant of 13,587 stock options. These options give her the right to buy Eloxx Common Stock at a fixed exercise price, representing equity-based compensation rather than an open-market trade.
What are the key terms of Nina S. Kjellson’s Eloxx (ELOX) stock option grant?
The grant covers 13,587 stock options with an exercise price of $11.00 per share, expiring June 8, 2036. The options vest in 24 substantially equal monthly installments over two years, subject to her continued service with the company.
How many Eloxx (ELOX) stock options does Nina S. Kjellson hold after this Form 4?
After this reported transaction, Nina S. Kjellson holds 13,587 stock options directly. This figure reflects the full amount of the new grant, as disclosed, and represents her derivative position from this specific award at the time of the filing.
Is Nina S. Kjellson’s Eloxx (ELOX) option grant an open-market purchase or sale?
No, the filing describes the transaction as a grant or award acquisition of stock options, coded “A.” This indicates a compensation-related award granted by Eloxx, not an open-market purchase or sale of existing shares by the director.
How do the vesting terms affect Nina S. Kjellson’s Eloxx (ELOX) stock options?
The options vest in 24 substantially equal monthly installments, fully vesting on the second anniversary of the grant date. Vesting is conditioned on her continuous service, meaning she gains exercisable rights gradually rather than all at once on the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates